Free Trial
NASDAQ:BMGL

Basel Medical Group (BMGL) Stock Price, News & Analysis

Basel Medical Group logo
$2.43 -0.24 (-8.99%)
As of 06/20/2025 04:00 PM Eastern

About Basel Medical Group Stock (NASDAQ:BMGL)

Key Stats

Today's Range
$2.35
$2.70
50-Day Range
$1.02
$5.09
52-Week Range
$0.91
$9.40
Volume
371,173 shs
Average Volume
14.69 million shs
Market Capitalization
$44.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Receive BMGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter.

BMGL Stock News Headlines

Wall Street Zen Downgrades Basel Medical Group (NASDAQ:BMGL) to Sell
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Basel Medical Group Ltd.
BMGL Basel Medical Group Ltd
Basel Medical Group Ltd (BMGL)
See More Headlines

BMGL Stock Analysis - Frequently Asked Questions

Basel Medical Group's stock was trading at $4.50 at the beginning of 2025. Since then, BMGL stock has decreased by 46.0% and is now trading at $2.43.
View the best growth stocks for 2025 here
.

Basel Medical Group (BMGL) raised $9 million in an IPO on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00 per share.

Basel Medical Group's lock-up period expires on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its initial public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. After the expiration of Basel Medical Group's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BMGL
Web
N/A
Fax
N/A
Employees
36
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.05 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$44.85 million
Optionable
N/A
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:BMGL) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners